Dalvance receives FDA approval for the treatment of Staph and Strep skin infections
PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. MRSAImage/CDC Dalvance is intended to treat acute bacterial More...
New Survey: Most Americans don’t think global poverty can be overcome
The war to overcome global poverty is ongoing with some pointing to progress, but Amercians appear pessimistic. Most Americans see no end in sight, according to a survey sponsored by Compassion International. Christians More...
UC San Diego scientists discover ‘anthracimycin’, compound that kills anthrax, MRSA
Researchers from Scripps Institution of Oceanography at UC San Diego have discovered a compound from a microbe from the ocean that shows lethality against such bacterial pathogens as anthrax and MRSA and may set More...
Paratek Pharmaceutical’s ‘omadacycline’ gets QIDP designation from the FDA
Boston, MA company, Paratek Pharmaceuticals, Inc announced today that their lead product candidate, omadacycline received the Food and Drug Administration’s (FDA) Qualified Infectious Disease Product (QIDP) More...
